Kenneth Frazier stepping down as Merck CEO, becomes executive chairman

USATODAY.com

04 Feb 2021 0 shares 1 views

USATODAY.com

Published 04 Feb 2021

Kenneth Frazier, who tussled with President Donald Trump, is stepping down as CEO of Merck in a shakeup for the pharmaceutical giant

Merck’s Kenneth Frazier to Retire as CEO at End of June

Robert Davis, currently executive vice president of global services and chief financial officer, will take over as CEO on July 1.

Upworthy 04 Feb 2021

Kenilworth, NJ (AP) — Merck posted a big fourth-quarter loss due to a hefty charge and much higher spending on research,..

SeattlePI.com 04 Feb 2021